特集 : 国別レポートが13,000件から検索可能になりました!

特集 : 海外市場の委託調査がセミカスタムベースでお手軽にできます

株式会社グローバルインフォメーション
市場調査レポート
商品コード
422789

血管ステント市場予測:材料(金属、ポリマー、生分解性ポリマー)、地域別

Vascular Stents Market: By Material (Metal Stents, Standard Polymeric Stents, and Biodegradable Polymeric Stents) & By Region (Europe, North America, Asia-Pacific, RoW)-Forecast 2019-2024

出版日: | 発行: IndustryARC | ページ情報: 英文 | 納期: 2-3営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=106.45円
血管ステント市場予測:材料(金属、ポリマー、生分解性ポリマー)、地域別
出版日: 2018年12月07日
発行: IndustryARC
ページ情報: 英文
納期: 2-3営業日
  • 全表示
  • 概要
  • 目次
概要

当レポートでは、血管ステントの世界市場について調査し、市場の促進・抑制要因、市場の機会や課題、ステント材料、地域別の市場動向を分析・予測し、競合分析や主要企業のプロファイルなどをまとめています。

第1章 血管ステント市場の概要

第2章 エグゼクティブサマリー

第3章 血管ステント市場の情勢

  • 市場シェア分析
  • 競合分析
  • 製品ベンチマーク
  • エンドユーザーのプロファイル
  • トップ5社の財務分析

第4章 市場力学

  • 市場の促進要因
  • 市場の抑制要因
  • 市場の機会
  • 市場の課題
  • ファイブフォース分析

第5章 戦略分析

  • バリューチェーン分析
  • 価格分析
  • 市場機会分析
  • 製品・市場のライフサイクル分析
  • 供給源・販売元

第6章 血管ステント市場:材料別

  • 金属ステント
  • 標準ポリマーステント
  • 生分解性ポリマーステント

第7章 血管ステント市場:地域別

  • 欧州
  • アジア太平洋
  • 北米
  • その他(RoW)

第8章 血管ステント:エントロピー

  • 市場拡大
  • 技術発展
  • 合併・買収・合弁事業
  • 供給・契約

第9章 企業プロファイル

第10章 付録

目次

Vascular stents are tiny wire mesh tubes made up of metal or plastic mesh like materials and are placed into blood vessels, arteries or other hollow structures to open narrowed vessels and reduce the chances of chest pain or heart attack. The process for placement of vascular stent into a body is known as vascular stenting. Globally, development of efficient and advanced technology, rise in the awareness among people regarding vascular stenting, increasing government initiatives across the globe, growing number of patients suffering from cardiovascular disease, and rising demand for minimally invasive surgeries are the prime growth drivers of the vascular stents market. In addition, an increase in adoption of vascular stents in emerging economies such as China, India and others, will create new opportunities for the vascular stents market. However, higher cost of research and development, higher cost of vascular stents, and availability of alternative therapies such as angioplasty and others are the key restraints for the vascular stents market.

Geographically, North America dominated the vascular stents market, because of the growing number of patients suffering from cardiovascular diseases, high medical reimbursement facilities, and technological advancement. Asia Pacific is projected to have the fastest growth, owing to a rapidly increasing aging population, rise in consumer awareness, increasing healthcare expenditure favourable government policies, modernization of healthcare infrastructure, and growing medical tourism industry in developing nations such as China, and India in this region. Among all the material, metal stents has the highest market share in the vascular stents market.

This report identifies the vascular stents market size for the years 2014-2016, and forecast of the same till the year 2022. It also highlights the market drivers, restraints, growth indicators, challenges, and other key aspects with respect to the vascular stents market.

This report segments the vascular stents market on the basis of material, and regional market as follows:

The report has focused study on vascular stents market on the basis of material such as: Metal Stents, Standard Polymeric Stents, and Biodegradable Polymeric Stents

This report has been further segmented into major regions, which includes detailed analysis of each region such as: North America, Europe, Asia-Pacific (APAC), and Rest of the World (RoW) covering all the major country level markets in each of the region

This report identifies all the major companies operating in the vascular stents market. Some of the major companies' profiles in detail are as follows:

Goodman Co. Ltd.

InnoCore Technologies BV.

Boston Scientific Corporation

MicroPort Scientific Corp.

Reva Medical Inc.

Table of Contents

1. Vascular Stents Market - Overview

2. Executive Summary

3. Vascular Stents Market Landscape

  • 3.1. Market Share Analysis
  • 3.2. Comparative Analysis
  • 3.3. Product Benchmarking
  • 3.4. End User Profiling
  • 3.5. Top 5 Financials Analysis

4. Vascular Stents Market- Forces

  • 4.1. Drivers
    • 4.1.1. Development of efficient and advance technology
    • 4.1.2. Growing number of patients suffering from cardiovascular disease
  • 4.2. Restraints
    • 4.2.1. Higher cost of vascular stents
  • 4.3. Opportunities
    • 4.3.1. Emerging economies
  • 4.4. Challenges
  • 4.5. Porter's Five Forces Analysis
    • 4.5.1. Bargaining Power of Suppliers
    • 4.5.2. Bargaining Power of Buyers
    • 4.5.3. Threat of New Entrants
    • 4.5.4. Threat of Substitutes
    • 4.5.5. Degree of Competition

5. Vascular Stents Market- Strategic Analysis

  • 5.1. Value Chain Analysis
  • 5.2. Pricing Analysis
  • 5.3. Opportunities Analysis
  • 5.4. Product/Market Life Cycle Analysis
  • 5.5. Suppliers and Distributors

6. Vascular Stents Market, By Material

  • 6.1. Metal Stents
  • 6.2. Standard Polymeric Stents
  • 6.3. Biodegradable Polymeric Stents

7. Vascular Stents Market, By Geography

  • 7.1. Europe
    • 7.1.1. Germany
    • 7.1.2. France
    • 7.1.3. Italy
    • 7.1.4. Spain
    • 7.1.5. Russia
    • 7.1.6. U.K.
    • 7.1.7. Rest of Europe
  • 7.2. Asia Pacific
    • 7.2.1. China
    • 7.2.2. India
    • 7.2.3. Japan
    • 7.2.4. South Korea
    • 7.2.5. Rest of Asia-Pacific
  • 7.3. North America
    • 7.3.1. U.S.
    • 7.3.2. Canada
    • 7.3.3. Mexico
  • 7.4. Rest of the World (RoW)
    • 7.4.1. Brazil
    • 7.4.2. Rest of RoW

8. Vascular Stents - Entropy

  • 8.1. Expansion
  • 8.2. Technological Developments
  • 8.3. Merger & Acquisitions, and Joint Ventures
  • 8.4. Supply- Contract

9. Company Profiles (Overview, Financials, SWOT Analysis, Developments, Product Portfolio)

  • 9.1. Goodman Co. Ltd.
  • 9.2. InnoCore Technologies BV.
  • 9.3. Boston Scientific Corporation
  • 9.4. MicroPort Scientific Corp.
  • 9.5. Reva Medical Inc.
  • 9.6. Cook Medical
  • 9.7. Medtronic Inc.
  • 9.8. Allvivo Vascular Inc.
  • 9.9. Stentys SA,
  • 9.10. Abbott Vascular

More than 40 Companies are profiled in this Research Report, Complete List available on Request*

"*Financials would be provided on a best efforts basis for private companies"

10. Appendix

  • 10.1. Abbreviations
  • 10.2. Sources
  • 10.3. Research Methodology
  • 10.4. Bibliography
  • 10.5. Compilation of Expert Insights
  • 10.6. Disclaimer
株式会社グローバルインフォメーション
© Copyright 1996-2020, Global Information, Inc. All rights reserved.